<it>MSH2 </it>and <it>MLH1 </it>testing

<it>MSH2 </it>and <it>MLH1 </it>testing

Bibliographic Details
Main Authors:	Kurzawski Grzegorz, Suchy Janina, Lubiński Jan
Format:	Article
Language:	English
Published:	BMC 2008-06-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/6/2/83

Similar Items

<it>MSH6 </it>syndrome
by: Suchy Janina, et al.
Published: (2008-06-01)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
by: Muhammad Usman Rashid, et al.
Published: (2019-10-01)

IMMUNOHISTOCHEMICAL STUDY OF MSH2, MSH6, PMS2, MLH1 IN EVALUATION OF DIFFERENTIATION GRADE OF COLON ADENOCARCINOMA
by: G. A. Raskin, et al.
Published: (2016-02-01)

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
by: Dowty JG, et al.
Published: (2012-04-01)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
by: Nayê Balzan Schneider, et al.
Published: (2018-05-01)

Cancer risk in <it>MLH1</it>, <it>MSH2 </it>and <it>MSH6 </it>mutation carriers; different risk profiles may influence clinical management
by: Ramsoekh Dewkoemar, et al.
Published: (2009-12-01)

Simultaneous Analysis of MLH1, MSH2, MSH6, PMS2 and KRAS in Patients with Gastric and Colon Cancer Using Stochastic Sensors
by: Damaris-Cristina Gheorghe, et al.
Published: (2022-09-01)

Rare single‐nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome
by: Seyed Mohsen Mirabdolhosseini, et al.
Published: (2024-01-01)

Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
by: Assim Khattab Hasan, et al.
Published: (2023-01-01)

Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age
by: Taha Reşid Özdemir, et al.
Published: (2019-01-01)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
by: Mazurek A, et al.
Published: (2012-04-01)

Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
by: Inga Hinrichsen, et al.
Published: (2014-01-01)

P046: Involvement of MLH1 and MSH2 genes in hereditary susceptibility to CRC in the Moroccan population
by: Abdelhamid Bouramtane, et al.
Published: (2023-01-01)

Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.
by: Dandan Li, et al.
Published: (2013-01-01)

Aberrantly Methylated MGMT, hMLH1 and hMSH2 in Tumor and Serum DNA of Gliomas Patients
by: Chanqing ZHENG, et al.
Published: (2009-02-01)

Določanje polimorfizmov in mutacij v genih MLH1 in MSH2 pri nepolipoznem raku debelega črevesa
by: Vida Stegel, et al.
Published: (2008-12-01)

Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474)
by: Ahmed Mohammed Salman, et al.
Published: (2024-01-01)

Link between immunoexpression of hMLH1 and hMSH2 proteins and clinical-epidemiological aspects of actinic cheilitis
by: Dmitry José de Santana Sarmento, et al.
Published: (2016-08-01)

Investigation of APC, MLH1 and MSH2 Mutations in Patients with Hereditary Colorectal Carcinoma: A Single Center Experience
by: Mehmet Buğrahan Düz
Published: (2021-01-01)

In silico and in vivo splicing analysis of <it>MLH1 </it>and <it>MSH2 </it>missense mutations shows exon- and tissue-specific effects
by: Guanti Ginevra, et al.
Published: (2006-09-01)

Penetrance of colorectal cancer among <it>MLH1</it>/<it>MSH2 </it>carriers participating in the colorectal cancer familial registry in Ontario
by: Choi Yun-Hee, et al.
Published: (2009-08-01)

Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
by: Tomlinson, I, et al.
Published: (1996)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
by: Catto, J, et al.
Published: (2003)

hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
by: Kim, J, et al.
Published: (2001)

Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line
by: Naser Hameed Saleh, et al.
Published: (2023-01-01)

Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.
by: Fulan Hu, et al.
Published: (2013-01-01)

Germline mutations in the mismatch repair genes hMLH1 and hMSH2 may predispose to the formation of multiple adenomatous polyps
by: Fearnhead, N, et al.
Published: (2002)

Frequent Novel Variations Within MSH2 and MLH1 Genes in a Subset of Iranian Families With Hereditary Non-Polyposis Colorectal Cancer
by: Shadi Javan, et al.
Published: (2019-05-01)

P073: Novel high-throughput functional models for MLH1, MSH2, and PMS2 have high accuracy for clinical variant classification
by: David Stafford, et al.
Published: (2024-01-01)

Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer‐predisposing genes in familial early‐onset colorectal cancer
by: Nayeralsadat Fatemi, et al.
Published: (2023-09-01)

Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes
by: Nic Gabriel Reitsam, et al.
Published: (2022-10-01)

Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort
by: Jubb, A, et al.
Published: (2002)

DNA testing for variants conferring low or moderate increase in the risk of cancer
by: Kurzawski Grzegorz, et al.
Published: (2008-06-01)

Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.
by: Abram Bunya Kamiza, et al.
Published: (2015-01-01)

A rare large duplication of MLH1 identified in Lynch syndrome
by: Abhishek Kumar, et al.
Published: (2021-01-01)

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in <i>MLH1</i> and <i>MSH2</i>: A Prospective Lynch Syndrome Database Study
by: Mev Dominguez-Valentin, et al.
Published: (2021-06-01)

Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report
by: Yi-Ching Huang, et al.
Published: (2024-06-01)

The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria
by: Ashton Katie A, et al.
Published: (2006-05-01)

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
by: Mariann Unhjem Wiik, et al.
Published: (2021-05-01)

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk
by: Kurzawski Grzegorz, et al.
Published: (2008-04-01)